IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

The Case for Outsourcing Peptides Manufacture

2:03 AM MDT | August 26, 2010

An article by the American Peptide Company (Sunnyvale, CA)   These days, many companies facing increasing pressure, to reduce costs, risk, and time-to-market, and maximize efficiencies, have converged on a similar strategy: outsource non-core functions. This is why companies as small as start-up biotechs and as large as the pharmaceutical and biopharmaceutical majors, outsource peptide production needs ever more increasingly. Whether a company needs research-grade materials or GMP-grade materials, they are realizing cost effectiveness and efficiency by...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa